Cargando…
Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
Artemisinin (ARS) and its derivatives, which are clinically used antimalarial agents, have shown antitumor activities. Their therapeutic potencies, however, are limited by their low solubility and poor bioavailability. Here, through a pharmacophore hybridization strategy, we synthesized ARS-drug con...
Autores principales: | Li, Xiaoguang, Zhou, Yu, Liu, Yanling, Zhang, Xu, Chen, Tao, Chen, Kerong, Ba, Qian, Li, Jingquan, Liu, Hong, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161434/ https://www.ncbi.nlm.nih.gov/pubmed/27939426 http://dx.doi.org/10.1016/j.ebiom.2016.11.026 |
Ejemplares similares
-
Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
por: Yang, Chen, et al.
Publicado: (2019) -
Safety, pharmacokinetics and efficacy of artemisinins in pregnancy
por: Ades, Veronica
Publicado: (2011) -
Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein
por: Li, Xiaoguang, et al.
Publicado: (2017) -
Hydrophilic Small Molecules That Harness Transthyretin
To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents
por: Pal, Arindom, et al.
Publicado: (2019) -
In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
por: Wilson, A. P., et al.
Publicado: (1981)